Tag: IBS

April 17, 2018

Biomerica Announces Third Quarter Financial Results

Biomerica (Nasdaq:BMRA) today reported net sales of $4,433,785 for the nine months ending February 28, 2018, compared to $4,342,247 for...
March 19, 2018

Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor

Knight Therapeutics (TSX:GUD) announced today a license agreement with Ardelyx (NASDAQ:ARDX) that provides Knight with exclusive rights to commercialize tenapanor...
October 18, 2017

Focus Graphite Unveils Its Highly Conductive Ultrafine and Expanded Graphites For Battery Cathodes

Focus Graphite Unveils Its Highly Conductive Ultrafine and Expanded Graphites For Battery Cathodes Creating a Complete Line of Value-Added Lac...
October 10, 2017

Focus Graphite Introduces Its New “Superfine Grade” of Coated Spherical Graphite for Lithium Batteries to the International Battery Industry

Focus Graphite Inc. (TSXV:FMS,OTCQX:FCSMF,FWB:FKC) is pleased to announce the introduction of a Superfine Grade of coated spherical graphite product sourced from...
August 30, 2017

Biomerica Announces Fiscal Year End 2017 Financial Results

Biomerica released their financial results for their fiscal 2017 year.
June 21, 2017

AXIM Biotech Secures Funding for Trials and Studies

AXIM Biotechnologies secured funding to continue its trials and cannabinoid research.
April 13, 2017

IntelGenx and RedHill Get Marketing Approval in Luxembourg

IntelGenx in collaboration with RedHill Biopharma announced the Ministry of Health of Luxembourg has granted national marketing authorization for RIZAPORT,...